Knowledge is evolving regarding numerous clinical aspects of immune thrombocytopenia purpura (ITP), and there remains significant variability in clinical practice patterns for its management. This activity features ITP experts James Bussel, MD and Nichola Cooper, MD sharing their insights about data recently released in either abstract or full publication form pertaining to pharmacotherapy for ITP, with a focus on the use of thrombopoietin (TPO) receptor agonists.
Earn CME credit for this activity at the following location:
http://elc.imedex.com/ELC/Specialty-Search.aspx?search=Hematology
© 2017 Imedex, LLC.
Advertisement